REFERENCES
- Cook, G. C., Mulligan, R. & Sherlock, S. 1971. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Quart. J. Med. 40, 159–185.
- Cook, G. C., Velasco, M. & Sherlock, S. 1968. Effect of corticosteroid therapy on bromo-sulphthalein excretion in active chronic hepatitis. Gut 9, 270–283.
- Copenhagen Study Group for Liver Diseases. 1969. Effect of Prednisone on the survival of patients with cirrhosis of the liver. Lancet 1, 119.
- Kater, R. M. H., Harrison, D. D. & Mistilis, S. P. 1967. Alterations in sulphobromophthalein sodium removal from blood in patients with pruritis of pregnancy. Gastroenterology 53, 941–946.
- Mistilis, S. P. & Blackburn, C. R. B. 1970. Active chronic hepatitis. Amer. J. Med. 48, 484–495.
- Mistilis, S. P. & Blackburn, C. R. B. 1967. 6-Mercaptopurine and azathioprine in the treatment of active chronic hepatitis. Aust. Ann. Med. 16, 305–311.
- Mistilis, S. P., Skyring, A. P. & Blackburn, C. R. B. 1968. The natural history of active chronic hepatitis: 1. Clinical features, course, diagnostic criteria, morbidity, mortality and survival. Aust. Ann. Med. 17. 214–223.
- Page, A. R., Good, R. A. & Pollara, B. 1969. Long-term results of therapy in patients with chronic liver disease associated with hyper-gammaglobulinaemia. Amer. J. Med. 47, 765–774.
- Preisig, R., Williams, R., Sweeting, J. et al. 1966. Changes in sulphobromophthalein transport and storage by the liver during viral hepatitis in man. Amer. J. Med. 40, 170–183.
- Rao, C. R. 1965. pp. 480–482 in Linear Statistical Inference and its Applications. John Wiley and Sons, New York.
- Wheeler, H. O., Meltzer, J. I. & Bradley, S. E. 1960. Biliary transport and hepatic storage of sulphobromophthalein sodium in unanesthetized dog, in normal man and in patients with hepatic disease. J. clin. Invest. 39, 1131–1138.